deltatrials
Unknown OBSERVATIONAL NCT05278299

Asia Glaucoma Registry

Sponsor: The University of Hong Kong

Conditions POAG
Updated 4 times since 2022 Last updated: Mar 3, 2022 Started: Oct 1, 2021 Primary completion: Sep 30, 2022 Completion: Sep 30, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates POAG and is currently ongoing. The University of Hong Kong leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Apr 2022 – ~Apr 2024 · 24 months · monthly snapshotActive Not Recruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Apr 2024 — Jul 2024 [monthly]

    Unknown Status

    Status: Active Not Recruiting → Unknown Status

  4. Apr 2022 — Apr 2024 [monthly]

    Active Not Recruiting

    First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The University of Hong Kong
Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations